Alexandre Houy

Title: Alexandre Houy: Innovator in Immunotherapy

Introduction

Alexandre Houy is a prominent inventor based in Vitry sur Seine, France. He has made significant contributions to the field of immunotherapy, particularly in targeting tumor neoantigenic peptides. His innovative approach aims to enhance cancer treatment through the development of specific immunogenic compositions.

Latest Patents

Alexandre Houy holds 1 patent for his work titled "Immunotherapy targeting tumor neoantigenic peptides." This patent outlines a method for selecting tumor neoantigenic peptides, which includes the development of vaccines or immunogenic compositions, antibodies, and immune cells derived from these peptides. The ultimate goal of this research is to improve therapeutic options for cancer patients.

Career Highlights

Throughout his career, Alexandre has worked with esteemed organizations such as Institut Curie and Mnemo Therapeutics. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer immunotherapy.

Collaborations

Some of Alexandre's notable coworkers include Sebastian Amigorena and Marianne Burbage. Their collaborative efforts have further advanced the understanding and application of immunotherapy in clinical settings.

Conclusion

Alexandre Houy is a key figure in the development of innovative cancer therapies through his research on tumor neoantigenic peptides. His contributions are paving the way for more effective treatments in the fight against cancer.